We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
Turnover
15.26%
1-Year Est. Return
41.24%
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$67.5B
AUM Growth
+$10.9B
(+19%)
Cap. Flow
+$12.7B
Cap. Flow
% of AUM
18.75%
Top 10 Holdings %
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195
Avg Time Held
6.5
years
Top 10 Avg Time Held
5.9
years
Top 20 Avg Time Held
5.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$19.7B |
| 2 |
Walmart Inc
WMT
|
+$729M |
| 3 |
Kimberly-Clark
KMB
|
+$33.1M |
| 4 |
Erie Indemnity
ERIE
|
+$26.7M |
| 5 |
Becton Dickinson
BDX
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$799M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
Microsoft
MSFT
|
+$445M |
| 4 |
Amazon
AMZN
|
+$321M |
| 5 |
Broadcom
AVGO
|
+$274M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.2% |
| 2 | Technology | 23.92% |
| 3 | Consumer Staples | 7.59% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Communication Services | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1651
Cullinan Oncology
CGEM
$874M
| $149K | ﹤0.01% |
10,465
-2,024
| -16% | -$26K |
2024 Q3
6 quarters
|
|
1652
ADT
ADT
$5.06B
| $145K | ﹤0.01% |
22,136
+7,803
| +54% | +$58.6K |
2025 Q4
1 quarter
|
|
1653
Enovix
ENVX
$577M
| $145K | ﹤0.01% |
27,964
-2,878
| -9% | -$18K |
2022 Q2
15 quarters
|
|
1654
Biohaven
BHVN
$1.67B
| $144K | ﹤0.01% |
17,045
-93
| -0.5% | -$1.02K |
2023 Q4
9 quarters
|
|
1655
USA Today Co
TDAY
$1.05B
| $144K | ﹤0.01% |
20,450
-5,314
| -21% | -$32.5K |
2020 Q2
23 quarters
|
|
1656
MFA Financial
MFA
$674M
| $143K | ﹤0.01% |
14,937
-3,892
| -21% | -$38.4K |
2013 Q2
51 quarters
|
|
1657
Blaize Holdings
BZAI
$38.7M
| $143K | ﹤0.01% |
78,549
-5,560
| -7% | -$8.21K |
2025 Q3
2 quarters
|
|
1658
New Mountain Finance
NMFC
$644M
| $143K | ﹤0.01% |
18,406
+4,147
| +29% | +$34.6K |
2023 Q1
12 quarters
|
|
1659
MannKind Corp
MNKD
$1.01B
| $142K | ﹤0.01% |
58,132
-10,998
| -16% | -$49.1K |
2017 Q4
33 quarters
|
|
1660
Annexon
ANNX
$664M
| $142K | ﹤0.01% |
25,595
+897
| +4% | +$5.05K |
2024 Q3
6 quarters
|
|
1661
Teladoc Health
TDOC
$1.08B
| $141K | ﹤0.01% |
25,804
-6,728
| -21% | -$37.7K |
2024 Q3
6 quarters
|
|
1662
The RealReal
REAL
$1.34B
| $140K | ﹤0.01% |
15,456
-2,949
| -16% | -$37.3K |
2024 Q3
6 quarters
|
|
1663
Omeros
OMER
$1.15B
| $139K | ﹤0.01% |
13,118
-2,053
| -14% | -$24.2K |
2024 Q3
6 quarters
|
|
1664
Arbutus Biopharma
ABUS
$842M
| $137K | ﹤0.01% |
30,551
-5,610
| -16% | -$24.5K |
2020 Q4
21 quarters
|
|
1665
Infosys
INFY
$49.4B
| $137K | ﹤0.01% |
+10,148
| New | +$159K |
2026 Q1
0 quarters
|
|
1666
NCR Voyix
VYX
$1.07B
| $137K | ﹤0.01% |
21,649
-5,395
| -20% | -$47.6K |
2024 Q3
6 quarters
|
|
1667
Capitol Federal Financial
CFFN
$1.03B
| $136K | ﹤0.01% |
19,139
-4,787
| -20% | -$34.1K |
2013 Q2
51 quarters
|
|
1668
Evolv Technologies
EVLV
$755M
| $136K | ﹤0.01% |
22,517
-5,428
| -19% | -$31.8K |
2023 Q2
11 quarters
|
|
1669
Adtran
ADTN
$530M
| $136K | ﹤0.01% |
10,782
-2,810
| -21% | -$28.5K |
2022 Q3
14 quarters
|
|
1670
First Advantage
FA
$3.48B
| $135K | ﹤0.01% |
11,484
-2,986
| -21% | -$36.5K |
2024 Q4
5 quarters
|
|
1671
Surgery Partners
SGRY
$1.94B
| $134K | ﹤0.01% |
11,213
-2,922
| -21% | -$41.9K |
2023 Q1
12 quarters
|
|
1672
RLJ Lodging Trust
RLJ
$1.84B
| $133K | ﹤0.01% |
17,991
-7,119
| -28% | -$55.4K |
2013 Q2
51 quarters
|
|
1673
Nokia
NOK
$53.2B
| $133K | ﹤0.01% |
16,533
-1,039
| -6% | -$7.63K |
2023 Q4
9 quarters
|
|
1674
Burford Capital
BUR
$727M
| $132K | ﹤0.01% |
29,172
-7,611
| -21% | -$66.6K |
2024 Q3
6 quarters
|
|
1675
Redwire
RDW
$2.21B
| $131K | ﹤0.01% |
15,384
+2,005
| +15% | +$19.6K |
2025 Q4
1 quarter
|
|
Similar funds
ProShare Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 0.01% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.
- ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
- ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
- ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
- ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
- ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
- ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.